T0	Participants 103 123	suppressed patients.
T1	Participants 320 439	virologically suppressed patients (HIV-1 RNA <400 copies/mL for > or =3 months) on stable (> or =6 months) therapy with
T2	Participants 520 602	Eighty-nine suppressed patients > or =18 years old with CD4 counts >50 cells/mm(3)
T3	Participants 753 772	Eighty-one patients
T4	Participants 1576 1694	Patients who experience virologic suppression with a regimen of lamivudine 150 mg BID in combination with stavudine/PI